Skip to main content
SupplementScience

Benefits of Devil's Claw

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Lower back pain — Chrubasik et al. (2003, n=197) found devil's claw extract (50mg harpagosides/day) comparably effective to rofecoxib 12.5mg for acute low back pain over 6 weeks
  • Osteoarthritis — a 2014 systematic review (Oltean et al., 14 studies) concluded devil's claw reduces OA pain, with high-dose extract (>60mg harpagosides) showing consistent benefits
  • COX-2 inhibition — harpagosides suppress COX-2 expression and reduce prostaglandin E2 synthesis in vitro and in vivo without significantly affecting COX-1
  • Cytokine modulation — in vitro studies show harpagosides inhibit TNF-alpha, IL-1beta, and IL-6 production by stimulated monocytes
  • Analgesic effect — a 4-month open study (Leblan et al., 2000, n=122) found 61% of patients could reduce or stop NSAID/analgesic use while taking devil's claw

What the Research Says

Devil's claw is one of the most extensively studied herbal anti-inflammatories in Europe, with approval from German Commission E and ESCOP for degenerative musculoskeletal disorders. The landmark Chrubasik et al. (2003) trial found it comparable to rofecoxib (Vioxx) for acute low back pain. A systematic review by Oltean et al. (2014) confirmed benefit for OA across multiple trials. The Leblan et al. (2000) open study showed 61% of patients could reduce NSAID use. Harpagosides are the primary active compounds, inhibiting COX-2 and multiple pro-inflammatory cytokines. The extract has a favorable safety profile compared to NSAIDs, though GI effects occur in some users and it should be avoided in peptic ulcer disease.

Related Conditions

Back PainOsteoarthritisInflammation
Full Devil's Claw Guide

References

  1. (). A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain. Rheumatology. DOI
  2. (). Herbal medicine for low-back pain. Cochrane Database of Systematic Reviews. DOI
  3. (). Harpagophytum procumbens in the treatment of knee and hip osteoarthritis: four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine. DOI